Advisor Group Holdings, Inc. Rain Therapeutics Inc. Transaction History

Advisor Group Holdings, Inc.

  • $40.6 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$0.84 - $1.22 $882 - $1,281
1,050 Added 4.61%
23,838 $28,000
Q3 2023

Nov 13, 2023
BUY
$0.82 - $1.42 $16,616 - $28,774
20,264 Added 802.85%
22,788 $19,000
Q2 2023

Aug 10, 2023
BUY
$1.09 - $9.93 $1,340 - $12,213
1,230 Added 95.05%
2,524 $3,000
Q1 2023

May 12, 2023
BUY
$7.77 - $12.47 $10,054 - $16,136
1,294 New
1,294 $11,000

Others Institutions Holding RAIN

# of Institutions
3
Shares Held
122K
Call Options Held
0
Put Options Held
0
View Full List

About Rain Therapeutics Inc.

RAIN Quotes by TradingView
  • Ticker RAIN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,837,400
  • Description
  • Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in...
More about RAIN
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email